The silent epidemic of COPD in Africa
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide.
1 It is one of the most common non-communicable diseases, aff ecting 329 million people, and this number is likely to be an underestimate. The global economic cost of COPD is US$2·1 trillion. 2 Yet it remains almost unknown in Africa. The prevalence of COPD in sub-Saharan Africa has been poorly studied. A meta-analysis 3 of nine crosssectional studies (fi ve from South Africa, two from Nigeria, one from Malawi, and one from Cape Verde) reported a prevalence ranging from 4·1% to 24·8%, depending on which diagnostic criterion was used. Of the nine studies, only one used population-based representative sampling and an internationally recognised case defi nition, whereas the other studies lacked robust designs and had inconsistent diagnostic criteria. Another meta-analysis 4 of an additional four studies from Africa reported that the prevalence of COPD varied widely depending on whether spirometry was used or not. The eight studies that defi ned COPD on the basis of symptoms reported a mean prevalence of 4·0% (range 2·1-8·9), whereas the fi ve that used spirometry reported a mean prevalence of 13·4% (9·4-22·1).
One of the main reasons why COPD prevalence studies are rare is the general lack of standardised epidemiological instruments and the need to do good quality post-bronchodilator spirometry, which requires considerable expertise and experience. 5 Studies that use symptom-based questionnaires lack suffi cient sensitivity and specifi city. Moreover, considerable controversy exists about which spirometric criterion should be used to defi ne COPD: a fi xed postbronchodilator FEV 1 to FVC ratio of 0·7, or a FEV 1 to FVC ratio less than the lower limit of normal. Each criterion has advantages and disadvantages, but the absence of an agreed standard has created confusion among epidemiologists wanting to study COPD prevalence. 5 In The Lancet Global Health, Frederik van Gemert and colleagues 6 present results of a cross-sectional study of COPD prevalence in 588 people in the Masindi district of Uganda, with COPD defi ned by post-bronchodilator spirometry. This study is one of the fi rst in subSaharan Africa to use a robust sampling strategy and an internationally accepted diagnostic method and criterion. The prevalence of COPD was 16·2%. The investigators also report that the prevalence of COPD did not diff er between men and women, around 40% of patients with COPD were aged 30-40 years, 31% of men and 74% of women with COPD had never smoked, nearly all individuals with and without COPD had been exposed to biomass smoke.
Smoke from biomass fuel is an important risk factor for COPD. From a global perspective, it might be more important than tobacco smoking. 7 In the study by van Gemert and colleagues, 6 93% of the study population used biomass fuel for cooking, as in most African countries. Women spent 3-5 h cooking with prolonged exposure to biomass smoke, often in poorly ventilated kitchens. This behaviour could explain why COPD is as common in women as in men, despite less smoking among women. Exposure to biomass smoke since childhood also explains why 40% of people with COPD in Uganda were young (30-40 years). In high-income countries, COPD prevalence studies traditionally include adults older than 40 years, because 15-20 years of exposure to tobacco smoke is needed before COPD begins to manifest.
Wheeze is a common symptom in patients with asthma and an uncommon symptom in COPD caused by tobacco smoke. The high prevalence of wheeze in this study suggests that COPD caused by biomass smoke might be a diff erent phenotype than COPD caused by tobacco smoke. Biomass COPD mainly aff ects airways, whereas tobacco smoke aff ects both airways and lung parenchyma. 8 What do these observations mean for countries in sub-Saharan Africa? van Gemert and colleagues have shown that high quality studies of COPD prevalence can be done with locally trained paramedical fi eld workers. COPD seems to be highly prevalent in Africa, yet remains almost unknown. It seems to aff ect mainly people aged 30-40 years and the major risk factors are tobacco smoking and biomass smoke exposure, although other risk factors, such as poverty, poor nutrition, history of lung tuberculosis, or HIV infection, might also be as important. More studies are needed to understand the true burden of COPD in Africa and the risk factors for the disease. However, improved surveillance is merely the fi rst step in addressing COPD in sub-Saharan Africa. be taught how to address COPD eff ectively; at present, diagnosis and treatment are grossly inadequate. 10 Health-care policy makers in sub-Saharan Africa need to take notice of the silently growing epidemic of COPD and start taking measures to both prevent and treat COPD eff ectively, before it gets out of hand.
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